An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
Titel:
An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer
Auteur:
Morgensztern, Daniel Karaseva, Nina Felip, Enriqueta Delgado, Ignacio Burdaeva, Olga Dómine, Manuel Lara, Primo Paik, Paul K. Lassen, Ulrik Orlov, Sergey Trigo, José Shomova, Marina Baker-Neblett, Katherine Vasquez, James Wang, Xiaowei Yan, Li Mitrica, Ionel DeYoung, M. Phillip Garrido, Pilar